AZ divests migraine drug to Grünenthal
admin 7th June 2017 Uncategorised 0AstraZeneca has sold global rights (ex Japan) for its migraine drug Zomig to Grünenthal, as it continues to shed products outside of its area of strategic focus.
More: AZ divests migraine drug to Grünenthal
Source: News